Norwegian health workers, who received AstraZeneca jabs, develop blood clots

Three health workers are being treated at the hospital for bleeding, blood clots and a low number of blood clots, Norwegian health authorities said Saturday.

Post by Karan Manral | Reuters

PUBLISHED ON MAR 13, 2021 09:32 PM IST

Three Norwegian health workers who recently received the AstraZeneca vaccine against COVID-19 are being treated in hospital for bleeding, blood clots and a low blood count, Norwegian health authorities said Saturday.

Norway halted on Thursday when that vaccine was released, following a similar move by Denmark. Iceland followed suit.

“We don’t know if the cases are related to the vaccine,” said Sigurd Hortemo, a senior doctor at the Norwegian Pharmaceutical Group at a news conference held with the Norwegian Institute of Public Health.

All three were under the age of 50.

The European medical regulator EMA would investigate all three incidents, Hortemo said.

“They have very unusual symptoms: swelling, blood clots and a low number of blood clots,” Steinar Madsen, Medical Director at the Norwegian Pharmaceutical Agency told the broadcaster NRK.

“They are very ill … We will take this very seriously,” he said, adding that authorities had been notified of the cases on Saturday.

AstraZeneca was not immediately available for comment.

Before moving to Denmark and Norway, Austria stopped using a batch of AstraZeneca images while investigating deaths from coagulation disorders and illness from lung embolism.

However, the EMA said Thursday that the benefits of the vaccine outweighed its risks and could continue.

Europe is struggling to accelerate vaccine distribution following delivery delays from Pfizer and AstraZeneca, even as a spike in cases amid a variety of more infectious viruses that have triggered new locks in countries such as Italy and France.

Related stories

This photograph shows a vial and sryinge in front of the AstraZeneca logo.  (Reuters)

This photograph shows a vial and sryinge in front of the AstraZeneca logo. (Reuters)

AFP

PUBLISHED ON MAR 13, 2021 02:08 PM IST

  • New Delhi decided to conduct the study after several countries banned the spread of ecological fear even as the World Health Organization said there was no reason to stop using Covid-19 injection at AstraZeneca .

This photograph shows a vial and sryinge in front of the AstraZeneca logo.  (Reuters)

This photograph shows a vial and sryinge in front of the AstraZeneca logo. (Reuters)

Reuters

PUBLISHED ON MAR 13, 2021 10:28 AM IST

Austria earlier stopped using the batch of AstraZeneca images while investigating a death from circulation and a case of lung disease.

UK-based AstraZeneca said its injection was safe, adding that it is

UK-based AstraZeneca said his injection was safe, adding that there was “no evidence” of higher blood risks. (AFP)

AFP

PUBLISHED ON MAR 13, 2021 08:58 AM IST

The World Health Organization (WHO), which said its vaccination advisory committee was examining the incoming safety data, confirmed that no causal link has been established between the AstraZeneca vaccine and clotting.

AstraZeneca vaccine product information states that humans should be kept under control

AstraZeneca vaccine outcome information states that people should be kept under “close observation for at least 15 minutes” after receiving the injection (AFP)

AFP

PUBLISHED ON MAR 12, 2021 07:33 PM IST

  • The development comes a day after the European Medicines Agency said it was investigating a separate case of blood clots that forced Denmark to stop using the injection.

This photograph (REUTERS) shows a vial and sryinge in front of the AstraZeneca logo.

This photograph (REUTERS) shows a vial and sryinge in front of the AstraZeneca logo.

Post by Karan Manral | AP

PUBLISHED ON MAR 12, 2021 05:52 PM IST

Several EU countries have suspended AstraZeneca vaccination over reports of blood clots in some people. Denmark was the first to suspend the use of the vaccine for a period of time on Thursday.

Close

.Source